Headache

+How to treat
In print

Headache

By John Mottershead
How to Treat Headache

John Mottershead describes the diagnostic headache consultation, before moving on to look at some of the different headache disorders. He provides up-to-date information on the best approaches to management of the most frequently encountered conditions, and includes a summary of non-pharmacological approaches and new treatments for headache

This continuing medical education activity has been endorsed by the RNZCGP and has been approved for up to 1 CME credit for continuing professional de, Educate small, BACK panel - grey
References

1. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17(11):954–76.

2. Thomson AN, White GE, West R. The prevalence of bad headaches including migraine in a multiethnic community. N Z Med J 1993;106(967):477–80.

3. International Headache Society. International Classification of Headache Disorders, 3rd edition. 2018. https://ichd-3.org

4. Charles A. The evolution of a migraine attack - a review of recent evidence. Headache 2013;53(2):413–19.

5. Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet 2021;397(10283):1496–504.

6. Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78(17):1337–45.

7. Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50(6):921–36.

8. Wakerley BR. Medication-overuse headache. Pract Neurol 2019;19(5):399–403.

9. Raffaelli B, Neeb L, Reuter U. Monoclonal antibodies for the prevention of migraine. Expert Opin Biol Ther 2019;19(12):1307–17.